HEMADY

Generic: DEXAMETHASONE

Manufacturer: Acrotech Biopharma Inc

Corticosteroid [EPC]Thalidomide Analog [EPC]Proteasome Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Alkylating Drug [EPC]
282,072
Total Reports
126,043
Serious Reports
46,139
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.36%)

Patient Demographics

Male
128,302
Female
120,886

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for HEMADY.

# Reaction Reports % of Total
1 OFF LABEL USE 21,283
7.6%
2 FATIGUE 16,488
5.9%
3 DIARRHOEA 16,484
5.9%
4 PLASMA CELL MYELOMA 13,765
4.9%
5 NAUSEA 13,425
4.8%
6 PNEUMONIA 13,273
4.8%
7 DEATH 12,866
4.6%
8 DRUG INEFFECTIVE 12,331
4.4%
9 NEUTROPENIA 11,213
4.0%
10 PYREXIA 10,568
3.8%
11 THROMBOCYTOPENIA 10,241
3.7%
12 DYSPNOEA 9,869
3.5%
13 ANAEMIA 8,764
3.1%
14 FEBRILE NEUTROPENIA 8,690
3.1%
15 ASTHENIA 8,481
3.0%
16 VOMITING 8,462
3.0%
17 NEUROPATHY PERIPHERAL 8,243
3.0%
18 RASH 7,940
2.8%
19 DISEASE PROGRESSION 7,261
2.6%
20 CONSTIPATION 6,703
2.4%
21 SEPSIS 5,968
2.1%
22 DECREASED APPETITE 5,869
2.1%
23 PLATELET COUNT DECREASED 5,740
2.1%
24 HEADACHE 5,490
2.0%
25 DIZZINESS 5,347
1.9%
26 PAIN 5,317
1.9%
27 INFECTION 5,112
1.8%
28 HYPOTENSION 4,781
1.7%
29 MALAISE 4,660
1.7%
30 ACUTE KIDNEY INJURY 4,627
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.